12/23/2025 | Press release | Distributed by Public on 12/23/2025 13:25
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM N-CSR
CERTIFIED SHAREHOLDER REPORT OF REGISTERED
MANAGEMENT INVESTMENT COMPANIES
Investment Company Act file number 811-06444
Legg Mason Partners Investment Trust
(Exact name of registrant as specified in charter)
One Madison Avenue, 17th Floor, New York, NY 10010
(Address of principal executive offices) (Zip code)
Marc A. De Oliveira
Franklin Templeton
100 First Stamford Place
Stamford, CT 06902
(Name and address of agent for service)
Registrant's telephone number, including area code: 877-6LM-FUND/656-3863
Date of fiscal year end: October 31
Date of reporting period: October 31, 2025
| ITEM 1. | REPORT TO STOCKHOLDERS |
(a) The Report to Shareholders is filed herewith
|
ClearBridge Large Cap Value Fund
|
|
|
Class 1[LCLIX]
|
Annual Shareholder Report | October 31, 2025
|
|
Class Name
|
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment*
|
|
Class 1
|
$54
|
0.52%
|
| * | Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher. |
|
Top contributors to performance:
|
|
|
↑
|
JPMorgan Chase performed well as investors looked forward to a lighter regulatory touch for banks and credit card issuers under a Republican administration. Shares were also helped by disciplined execution, resilient consumer spending and credit, and signs of increasing capital markets activity.
|
|
↑
|
Broadcom, in the IT sector, develops semiconductors and software for a range of applications. The stock performed well as results from U.S. hyperscalers continued to validate increased capex in support of artificial intelligence (AI) efforts, where Broadcom is a leader in the market for custom silicon.
|
|
↑
|
McKesson benefited from strong U.S. pharma and specialty distribution fundamentals, including Rx volumes and competitive pricing. The company also announced changes to its organizational structure and raised its earnings guidance.
|
|
Top detractors from performance:
|
|
|
↓
|
UnitedHealth Group shares dropped following news of higher utilization, increasing costs and revenue shortfalls in its Optum Health business. Concerns of poor execution were exacerbated by the resignation of its CEO and federal lawsuits against pharmacy benefit managers such as UnitedHealth's OptumRx.
|
|
↓
|
Venture Global failed to garner investor enthusiasm after its January IPO, as its inaugural earnings report disappointed, showing weaker margins, lighter volumes and higher operating costs. Macro and geopolitical uncertainties also created a challenging backdrop for the company.
|
|
↓
|
Edison International shares fell as California wildfires raised concerns about potential liabilities.
|
| ClearBridge Large Cap Value Fund | PAGE 1 | 7092-ATSR-1225 |
|
1 Year
|
5 Year
|
10 Year
|
|
|
Class 1
|
7.84
|
13.09
|
9.60
|
|
Russell 3000 Index
|
20.81
|
16.74
|
14.08
|
|
Russell 1000 Value Index
|
11.15
|
14.28
|
9.97
|
|
S&P 500 Index
|
21.45
|
17.64
|
14.64
|
|
Total Net Assets
|
$2,379,676,532
|
|
Total Number of Portfolio Holdings
|
56
|
|
Total Management Fee Paid
|
$9,436,173
|
|
Portfolio Turnover Rate
|
18%
|
| ClearBridge Large Cap Value Fund | PAGE 2 | 7092-ATSR-1225 |
| * | Does not include derivatives, except purchased options, if any. |
|
WHERE CAN I FIND ADDITIONAL INFORMATION ABOUT THE FUND?
|
|
|
Additional information is available on https://www.franklintempleton.com/regulatory-fund-documents, including its:
|
|
|
• prospectus • proxy voting information • financial information • holdings • tax information
|
| ClearBridge Large Cap Value Fund | PAGE 3 | 7092-ATSR-1225 |
|
ClearBridge Large Cap Value Fund
|
|
|
Class A[SINAX]
|
Annual Shareholder Report | October 31, 2025
|
|
Class Name
|
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment*
|
|
Class A
|
$82
|
0.79%
|
| * | Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher. |
|
Top contributors to performance:
|
|
|
↑
|
JPMorgan Chase performed well as investors looked forward to a lighter regulatory touch for banks and credit card issuers under a Republican administration. Shares were also helped by disciplined execution, resilient consumer spending and credit, and signs of increasing capital markets activity.
|
|
↑
|
Broadcom, in the IT sector, develops semiconductors and software for a range of applications. The stock performed well as results from U.S. hyperscalers continued to validate increased capex in support of artificial intelligence (AI) efforts, where Broadcom is a leader in the market for custom silicon.
|
|
↑
|
McKesson benefited from strong U.S. pharma and specialty distribution fundamentals, including Rx volumes and competitive pricing. The company also announced changes to its organizational structure and raised its earnings guidance.
|
|
Top detractors from performance:
|
|
|
↓
|
UnitedHealth Group shares dropped following news of higher utilization, increasing costs and revenue shortfalls in its Optum Health business. Concerns of poor execution were exacerbated by the resignation of its CEO and federal lawsuits against pharmacy benefit managers such as UnitedHealth's OptumRx.
|
|
↓
|
Venture Global failed to garner investor enthusiasm after its January IPO, as its inaugural earnings report disappointed, showing weaker margins, lighter volumes and higher operating costs. Macro and geopolitical uncertainties also created a challenging backdrop for the company.
|
|
↓
|
Edison International shares fell as California wildfires raised concerns about potential liabilities.
|
| ClearBridge Large Cap Value Fund | PAGE 1 | 7826-ATSR-1225 |
|
1 Year
|
5 Year
|
10 Year
|
|
|
Class A
|
7.53
|
12.84
|
9.37
|
|
Class A (with sales charge)
|
1.59
|
11.51
|
8.72
|
|
Russell 3000 Index
|
20.81
|
16.74
|
14.08
|
|
Russell 1000 Value Index
|
11.15
|
14.28
|
9.97
|
|
S&P 500 Index
|
21.45
|
17.64
|
14.64
|
|
Total Net Assets
|
$2,379,676,532
|
|
Total Number of Portfolio Holdings
|
56
|
|
Total Management Fee Paid
|
$9,436,173
|
|
Portfolio Turnover Rate
|
18%
|
| ClearBridge Large Cap Value Fund | PAGE 2 | 7826-ATSR-1225 |
| * | Does not include derivatives, except purchased options, if any. |
|
WHERE CAN I FIND ADDITIONAL INFORMATION ABOUT THE FUND?
|
|
|
Additional information is available on https://www.franklintempleton.com/regulatory-fund-documents, including its:
|
|
|
• prospectus • proxy voting information • financial information • holdings • tax information
|
| ClearBridge Large Cap Value Fund | PAGE 3 | 7826-ATSR-1225 |
|
ClearBridge Large Cap Value Fund
|
|
|
Class C[SINOX]
|
Annual Shareholder Report | October 31, 2025
|
|
Class Name
|
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment*
|
|
Class C
|
$159
|
1.54%
|
| * | Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher. |
|
Top contributors to performance:
|
|
|
↑
|
JPMorgan Chase performed well as investors looked forward to a lighter regulatory touch for banks and credit card issuers under a Republican administration. Shares were also helped by disciplined execution, resilient consumer spending and credit, and signs of increasing capital markets activity.
|
|
↑
|
Broadcom, in the IT sector, develops semiconductors and software for a range of applications. The stock performed well as results from U.S. hyperscalers continued to validate increased capex in support of artificial intelligence (AI) efforts, where Broadcom is a leader in the market for custom silicon.
|
|
↑
|
McKesson benefited from strong U.S. pharma and specialty distribution fundamentals, including Rx volumes and competitive pricing. The company also announced changes to its organizational structure and raised its earnings guidance.
|
|
Top detractors from performance:
|
|
|
↓
|
UnitedHealth Group shares dropped following news of higher utilization, increasing costs and revenue shortfalls in its Optum Health business. Concerns of poor execution were exacerbated by the resignation of its CEO and federal lawsuits against pharmacy benefit managers such as UnitedHealth's OptumRx.
|
|
↓
|
Venture Global failed to garner investor enthusiasm after its January IPO, as its inaugural earnings report disappointed, showing weaker margins, lighter volumes and higher operating costs. Macro and geopolitical uncertainties also created a challenging backdrop for the company.
|
|
↓
|
Edison International shares fell as California wildfires raised concerns about potential liabilities.
|
| ClearBridge Large Cap Value Fund | PAGE 1 | 7851-ATSR-1225 |
|
1 Year
|
5 Year
|
10 Year
|
|
|
Class C
|
6.72
|
11.96
|
8.54
|
|
Class C (with sales charge)
|
5.76
|
11.96
|
8.54
|
|
Russell 3000 Index
|
20.81
|
16.74
|
14.08
|
|
Russell 1000 Value Index
|
11.15
|
14.28
|
9.97
|
|
S&P 500 Index
|
21.45
|
17.64
|
14.64
|
|
Total Net Assets
|
$2,379,676,532
|
|
Total Number of Portfolio Holdings
|
56
|
|
Total Management Fee Paid
|
$9,436,173
|
|
Portfolio Turnover Rate
|
18%
|
| ClearBridge Large Cap Value Fund | PAGE 2 | 7851-ATSR-1225 |
| * | Does not include derivatives, except purchased options, if any. |
|
WHERE CAN I FIND ADDITIONAL INFORMATION ABOUT THE FUND?
|
|
|
Additional information is available on https://www.franklintempleton.com/regulatory-fund-documents, including its:
|
|
|
• prospectus • proxy voting information • financial information • holdings • tax information
|
| ClearBridge Large Cap Value Fund | PAGE 3 | 7851-ATSR-1225 |
|
ClearBridge Large Cap Value Fund
|
|
|
Class R[LCBVX]
|
Annual Shareholder Report | October 31, 2025
|
|
Class Name
|
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment*
|
|
Class R
|
$125
|
1.21%
|
| * | Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher. |
|
Top contributors to performance:
|
|
|
↑
|
JPMorgan Chase performed well as investors looked forward to a lighter regulatory touch for banks and credit card issuers under a Republican administration. Shares were also helped by disciplined execution, resilient consumer spending and credit, and signs of increasing capital markets activity.
|
|
↑
|
Broadcom, in the IT sector, develops semiconductors and software for a range of applications. The stock performed well as results from U.S. hyperscalers continued to validate increased capex in support of artificial intelligence (AI) efforts, where Broadcom is a leader in the market for custom silicon.
|
|
↑
|
McKesson benefited from strong U.S. pharma and specialty distribution fundamentals, including Rx volumes and competitive pricing. The company also announced changes to its organizational structure and raised its earnings guidance.
|
|
Top detractors from performance:
|
|
|
↓
|
UnitedHealth Group shares dropped following news of higher utilization, increasing costs and revenue shortfalls in its Optum Health business. Concerns of poor execution were exacerbated by the resignation of its CEO and federal lawsuits against pharmacy benefit managers such as UnitedHealth's OptumRx.
|
|
↓
|
Venture Global failed to garner investor enthusiasm after its January IPO, as its inaugural earnings report disappointed, showing weaker margins, lighter volumes and higher operating costs. Macro and geopolitical uncertainties also created a challenging backdrop for the company.
|
|
↓
|
Edison International shares fell as California wildfires raised concerns about potential liabilities.
|
| ClearBridge Large Cap Value Fund | PAGE 1 | 7090-ATSR-1225 |
|
1 Year
|
5 Year
|
10 Year
|
|
|
Class R
|
7.08
|
12.28
|
8.87
|
|
Russell 3000 Index
|
20.81
|
16.74
|
14.08
|
|
Russell 1000 Value Index
|
11.15
|
14.28
|
9.97
|
|
S&P 500 Index
|
21.45
|
17.64
|
14.64
|
|
Total Net Assets
|
$2,379,676,532
|
|
Total Number of Portfolio Holdings
|
56
|
|
Total Management Fee Paid
|
$9,436,173
|
|
Portfolio Turnover Rate
|
18%
|
| ClearBridge Large Cap Value Fund | PAGE 2 | 7090-ATSR-1225 |
| * | Does not include derivatives, except purchased options, if any. |
|
WHERE CAN I FIND ADDITIONAL INFORMATION ABOUT THE FUND?
|
|
|
Additional information is available on https://www.franklintempleton.com/regulatory-fund-documents, including its:
|
|
|
• prospectus • proxy voting information • financial information • holdings • tax information
|
| ClearBridge Large Cap Value Fund | PAGE 3 | 7090-ATSR-1225 |
|
ClearBridge Large Cap Value Fund
|
|
|
Class I[SAIFX]
|
Annual Shareholder Report | October 31, 2025
|
|
Class Name
|
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment*
|
|
Class I
|
$50
|
0.48%
|
| * | Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher. |
|
Top contributors to performance:
|
|
|
↑
|
JPMorgan Chase performed well as investors looked forward to a lighter regulatory touch for banks and credit card issuers under a Republican administration. Shares were also helped by disciplined execution, resilient consumer spending and credit, and signs of increasing capital markets activity.
|
|
↑
|
Broadcom, in the IT sector, develops semiconductors and software for a range of applications. The stock performed well as results from U.S. hyperscalers continued to validate increased capex in support of artificial intelligence (AI) efforts, where Broadcom is a leader in the market for custom silicon.
|
|
↑
|
McKesson benefited from strong U.S. pharma and specialty distribution fundamentals, including Rx volumes and competitive pricing. The company also announced changes to its organizational structure and raised its earnings guidance.
|
|
Top detractors from performance:
|
|
|
↓
|
UnitedHealth Group shares dropped following news of higher utilization, increasing costs and revenue shortfalls in its Optum Health business. Concerns of poor execution were exacerbated by the resignation of its CEO and federal lawsuits against pharmacy benefit managers such as UnitedHealth's OptumRx.
|
|
↓
|
Venture Global failed to garner investor enthusiasm after its January IPO, as its inaugural earnings report disappointed, showing weaker margins, lighter volumes and higher operating costs. Macro and geopolitical uncertainties also created a challenging backdrop for the company.
|
|
↓
|
Edison International shares fell as California wildfires raised concerns about potential liabilities.
|
| ClearBridge Large Cap Value Fund | PAGE 1 | 7003-ATSR-1225 |
|
1 Year
|
5 Year
|
10 Year
|
|
|
Class I
|
7.87
|
13.12
|
9.66
|
|
Russell 3000 Index
|
20.81
|
16.74
|
14.08
|
|
Russell 1000 Value Index
|
11.15
|
14.28
|
9.97
|
|
S&P 500 Index
|
21.45
|
17.64
|
14.64
|
|
Total Net Assets
|
$2,379,676,532
|
|
Total Number of Portfolio Holdings
|
56
|
|
Total Management Fee Paid
|
$9,436,173
|
|
Portfolio Turnover Rate
|
18%
|
| ClearBridge Large Cap Value Fund | PAGE 2 | 7003-ATSR-1225 |
| * | Does not include derivatives, except purchased options, if any. |
|
WHERE CAN I FIND ADDITIONAL INFORMATION ABOUT THE FUND?
|
|
|
Additional information is available on https://www.franklintempleton.com/regulatory-fund-documents, including its:
|
|
|
• prospectus • proxy voting information • financial information • holdings • tax information
|
| ClearBridge Large Cap Value Fund | PAGE 3 | 7003-ATSR-1225 |
|
ClearBridge Large Cap Value Fund
|
|
|
Class IS[LMLSX]
|
Annual Shareholder Report | October 31, 2025
|
|
Class Name
|
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment*
|
|
Class IS
|
$46
|
0.44%
|
| * | Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher. |
|
Top contributors to performance:
|
|
|
↑
|
JPMorgan Chase performed well as investors looked forward to a lighter regulatory touch for banks and credit card issuers under a Republican administration. Shares were also helped by disciplined execution, resilient consumer spending and credit, and signs of increasing capital markets activity.
|
|
↑
|
Broadcom, in the IT sector, develops semiconductors and software for a range of applications. The stock performed well as results from U.S. hyperscalers continued to validate increased capex in support of artificial intelligence (AI) efforts, where Broadcom is a leader in the market for custom silicon.
|
|
↑
|
McKesson benefited from strong U.S. pharma and specialty distribution fundamentals, including Rx volumes and competitive pricing. The company also announced changes to its organizational structure and raised its earnings guidance.
|
|
Top detractors from performance:
|
|
|
↓
|
UnitedHealth Group shares dropped following news of higher utilization, increasing costs and revenue shortfalls in its Optum Health business. Concerns of poor execution were exacerbated by the resignation of its CEO and federal lawsuits against pharmacy benefit managers such as UnitedHealth's OptumRx.
|
|
↓
|
Venture Global failed to garner investor enthusiasm after its January IPO, as its inaugural earnings report disappointed, showing weaker margins, lighter volumes and higher operating costs. Macro and geopolitical uncertainties also created a challenging backdrop for the company.
|
|
↓
|
Edison International shares fell as California wildfires raised concerns about potential liabilities.
|
| ClearBridge Large Cap Value Fund | PAGE 1 | 7977-ATSR-1225 |
|
1 Year
|
5 Year
|
10 Year
|
|
|
Class IS
|
7.92
|
13.19
|
9.72
|
|
Russell 3000 Index
|
20.81
|
16.74
|
14.08
|
|
Russell 1000 Value Index
|
11.15
|
14.28
|
9.97
|
|
S&P 500 Index
|
21.45
|
17.64
|
14.64
|
|
Total Net Assets
|
$2,379,676,532
|
|
Total Number of Portfolio Holdings
|
56
|
|
Total Management Fee Paid
|
$9,436,173
|
|
Portfolio Turnover Rate
|
18%
|
| ClearBridge Large Cap Value Fund | PAGE 2 | 7977-ATSR-1225 |
| * | Does not include derivatives, except purchased options, if any. |
|
WHERE CAN I FIND ADDITIONAL INFORMATION ABOUT THE FUND?
|
|
|
Additional information is available on https://www.franklintempleton.com/regulatory-fund-documents, including its:
|
|
|
• prospectus • proxy voting information • financial information • holdings • tax information
|
| ClearBridge Large Cap Value Fund | PAGE 3 | 7977-ATSR-1225 |
(b) Not applicable
| ITEM 2. | CODE OF ETHICS. |
(a) The Registrant has adopted a code of ethics that applies to its principal executive officers and principal financial and accounting officer.
(c) N/A
(d) N/A
(f) Pursuant to Item 19(a) (1), the Registrant is attaching as an exhibit a copy of its code of ethics that applies to its principal executive officers and principal financial and accounting officer.
| ITEM 3. | AUDIT COMMITTEE FINANCIAL EXPERT. |
The Board of Trustees of the Registrant has determined that Stephen R. Gross, possesses the technical attributes identified in Item 3 to Form N-CSR to qualify as an "audit committee financial expert," and has designated Stephen R. Gross as the Audit Committee's financial expert. Stephen R. Gross is an "independent" Trustee pursuant to paragraph (a)(2) of Item 3 to Form N-CSR.
Under applicable securities laws, a person determined to be an audit committee financial expert will not be deemed an "expert" for any purpose, including without limitation for the purposes of Section 11 of the Securities Act of 1933, as a result of being designated or identified as an audit committee financial expert. The designation or identification of a person as an audit committee financial expert does not impose on such person any duties, obligations, or liabilities greater than the duties, obligations, and liabilities imposed on such person as a member of the audit committee and board of directors in the absence of such designation or identification. The designation or identification of a person as an audit committee financial expert does not affect the duties, obligations, or liability of any other member of the audit committee or board of directors.
| ITEM 4. | PRINCIPAL ACCOUNTANT FEES AND SERVICES. |
a) Audit Fees. The aggregate fees billed in the last two fiscal years ending October 31, 2024 and October 31, 2025 (the "Reporting Periods") for professional services rendered by the Registrant's principal accountant (the "Auditor") for the audit of the Registrant's annual financial statements, or services that are normally provided by the Auditor in connection with the statutory and regulatory filings or engagements for the Reporting Periods, were $350,718 in October 31, 2024 and $354,225 in October 31, 2025.
b) Audit-Related Fees. The aggregate fees billed in the Reporting Periods for assurance and related services by the Auditor that are reasonably related to the performance of the Registrant's financial statements were $0 in October 31, 2024 and $0 in October 31, 2025.
(c) Tax Fees. The aggregate fees billed in the Reporting Periods for professional services rendered by the Auditor for tax compliance, tax advice and tax planning ("Tax Services") were $100,500 in October 31, 2024 and $100,500 in October 31, 2025. These services consisted of (i) review or preparation of U.S. federal, state, local and excise tax returns; (ii) U.S. federal, state and local tax planning, advice and assistance regarding statutory, regulatory or administrative developments, and (iii) tax advice regarding tax qualification matters and/or treatment of various financial instruments held or proposed to be acquired or held.
There were no fees billed for tax services by the Auditors to the Registrant's investment manager and any entity controlling, controlled by, or under common control with the investment manager that provides ongoing services to the Registrant ("Service Affiliates") during the Reporting Periods that required pre-approval by the Audit Committee.
d) All Other Fees. The aggregate fees billed in the Reporting Periods for products and services provided by the Auditor to the Registrant, other than the services reported in paragraphs (a) through (c) of this item, were $0 in October 31, 2024 and $0 in October 31, 2025.
There were no other non-audit services rendered by the Auditor to the Service Affiliates requiring pre-approval by the Audit Committee in the Reporting Periods.
(e) Audit Committee's pre-approval policies and procedures described in paragraph (c) (7) of Rule 2-01 of Regulation S-X.
(1) The Charter for the Audit Committee (the "Committee") of the Board of each registered investment company (the "Fund") advised by the Registrant's investment manager or one of their affiliates (each, an "Adviser") requires that the Committee shall approve (a) all audit and permissible non-audit services to be provided to the Fund and (b) all permissible non-audit services to be provided by the Fund's independent auditors to the Adviser and any service providers controlling, controlled by or under common control with the Adviser that provide ongoing services to the Fund ("Covered Service Providers") if the engagement relates directly to the operations and financial reporting of the Fund. The Committee may implement policies and procedures by which such services are approved other than by the full Committee.
The Committee shall not approve non-audit services that the Committee believes may impair the independence of the auditors. As of the date of the approval of this Audit Committee Charter, permissible non-audit services include any professional services (including tax services), that are not prohibited services as described below, provided to the Fund by the independent auditors, other than those provided to the Fund in connection with an audit or a review of the financial statements of the Fund. Permissible non-audit services may not include: (i) bookkeeping or other services related to the accounting records or financial statements of the Fund; (ii) financial information systems design and implementation; (iii) appraisal or valuation services, fairness opinions or contribution-in-kind reports; (iv) actuarial services; (v) internal audit outsourcing services; (vi) management functions or human resources; (vii) broker or dealer, investment adviser or investment banking services; (viii) legal services and expert services unrelated to the audit; and (ix) any other service the Public Company Accounting Oversight Board determines, by regulation, is impermissible.
Pre-approval by the Committee of any permissible non-audit services is not required so long as: (i) the aggregate amount of all such permissible non-audit services provided to the Fund, the Adviser and the Covered Service Providers constitutes not more than 5% of the total amount of revenues paid to the independent auditors during the fiscal year in which the permissible non-audit services are provided to (a) the Fund, (b) the Adviser and (c) any entity controlling, controlled by or under common control with the Adviser that provides ongoing services to the Fund during the fiscal year in which the services are provided that would have to be approved by the Committee; (ii) the permissible non-audit services were not recognized by the Fund at the time of the engagement to be non-audit services; and (iii) such services are promptly brought to the attention of the Committee and approved by the Committee (or its delegate(s)) prior to the completion of the audit.
(2) None of the services described in paragraphs (b) through (d) of this Item were performed in reliance on paragraph (c)(7)(i)(C) of Rule 2-01 of Regulation S-X.
(f) Not applicable.
(g) Non-audit fees billed by the Auditor for services rendered to the Registrant and the Service Affiliates during the reporting period were $811,835 in October 31, 2024 and $870,024 in October 31, 2025.
(h) Yes. The Registrant's Audit Committee has considered whether the provision of non-audit services that were rendered to Service Affiliates, which were not pre-approved (not requiring pre-approval), is compatible with maintaining the Auditor's independence. All services provided by the Auditor to the Registrant or to the Service Affiliates, which were required to be pre-approved, were pre-approved as required.
(i) Not applicable.
(j) Not applicable.
| ITEM 5. | AUDIT COMMITTEE OF LISTED REGISTRANTS. |
Not applicable.
| ITEM 6. | SCHEDULE OF INVESTMENTS. |
| (a) | Please see schedule of investments contained in the Financial Statements and Financial Highlights included under Item 7 of this Form N-CSR. |
| (b) | Not applicable. |
| ITEM 7. | FINANCIAL STATEMENTS AND FINANCIAL HIGHLIGHTS FOR OPEN-END MANAGEMENT INVESTMENT COMPANIES. |
|
Schedule of Investments
|
1
|
|
Statement of Assets and Liabilities
|
5
|
|
Statement of Operations
|
7
|
|
Statements of Changes in Net Assets
|
8
|
|
Financial Highlights
|
9
|
|
Notes to Financial Statements
|
15
|
|
Report of Independent Registered Public Accounting Firm
|
27
|
|
Important Tax Information
|
28
|
|
Changes in and Disagreements with Accountants
|
29
|
|
Results of Meeting(s) of Shareholders
|
29
|
|
Remuneration Paid to Directors, Officers and Others
|
29
|
|
Board Approval of Management and Subadvisory Agreements
|
30
|
|
Security
|
|
|
|
Shares
|
Value
|
|
Common Stocks - 98.0%
|
|||||
|
Communication Services - 5.6%
|
|||||
|
Entertainment - 0.8%
|
|||||
|
Walt Disney Co.
|
175,757
|
$19,793,754
|
|||
|
Interactive Media & Services - 3.6%
|
|||||
|
Alphabet Inc., Class A Shares
|
212,263
|
59,686,233
|
|||
|
Meta Platforms Inc., Class A Shares
|
39,469
|
25,589,726
|
|||
|
Total Interactive Media & Services
|
85,275,959
|
||||
|
Media - 1.2%
|
|||||
|
Comcast Corp., Class A Shares
|
975,908
|
27,164,399
|
|||
|
|
|||||
|
Total Communication Services
|
132,234,112
|
||||
|
Consumer Discretionary - 5.8%
|
|||||
|
Broadline Retail - 2.0%
|
|||||
|
Amazon.com Inc.
|
199,600
|
48,746,312
*
|
|||
|
Hotels, Restaurants & Leisure - 0.6%
|
|||||
|
Starbucks Corp.
|
175,483
|
14,191,310
|
|||
|
Specialty Retail - 3.2%
|
|||||
|
Home Depot Inc.
|
105,731
|
40,134,431
|
|||
|
O'Reilly Automotive Inc.
|
374,450
|
35,363,058
*
|
|||
|
Total Specialty Retail
|
75,497,489
|
||||
|
|
|||||
|
Total Consumer Discretionary
|
138,435,111
|
||||
|
Consumer Staples - 2.2%
|
|||||
|
Beverages - 1.0%
|
|||||
|
PepsiCo Inc.
|
169,082
|
24,701,189
|
|||
|
Household Products - 1.2%
|
|||||
|
Procter & Gamble Co.
|
189,900
|
28,555,263
|
|||
|
|
|||||
|
Total Consumer Staples
|
53,256,452
|
||||
|
Energy - 6.6%
|
|||||
|
Oil, Gas & Consumable Fuels - 6.6%
|
|||||
|
Chevron Corp.
|
309,234
|
48,772,387
|
|||
|
ConocoPhillips
|
483,018
|
42,920,979
|
|||
|
Enterprise Products Partners LP
|
1,407,968
|
43,351,335
|
|||
|
Exxon Mobil Corp.
|
195,700
|
22,380,252
|
|||
|
|
|||||
|
Total Energy
|
157,424,953
|
||||
|
Financials - 23.4%
|
|||||
|
Banks - 8.9%
|
|||||
|
Bank of America Corp.
|
1,168,274
|
62,444,245
|
|||
|
JPMorgan Chase & Co.
|
389,755
|
121,260,576
|
|||
|
PNC Financial Services Group Inc.
|
153,400
|
28,003,170
|
|||
|
Total Banks
|
211,707,991
|
||||
|
Security
|
|
|
|
Shares
|
Value
|
|
|
|||||
|
Capital Markets - 2.6%
|
|||||
|
Charles Schwab Corp.
|
651,968
|
$61,624,015
|
|||
|
Consumer Finance - 3.7%
|
|||||
|
American Express Co.
|
136,047
|
49,076,234
|
|||
|
Capital One Financial Corp.
|
172,650
|
37,981,274
|
|||
|
Total Consumer Finance
|
87,057,508
|
||||
|
Financial Services - 3.8%
|
|||||
|
Berkshire Hathaway Inc., Class B Shares
|
109,536
|
52,307,822
*
|
|||
|
Visa Inc., Class A Shares
|
113,068
|
38,526,790
|
|||
|
Total Financial Services
|
90,834,612
|
||||
|
Insurance - 4.4%
|
|||||
|
Marsh & McLennan Cos. Inc.
|
184,112
|
32,799,553
|
|||
|
Progressive Corp.
|
94,304
|
19,426,624
|
|||
|
Travelers Cos. Inc.
|
200,160
|
53,766,979
|
|||
|
Total Insurance
|
105,993,156
|
||||
|
|
|||||
|
Total Financials
|
557,217,282
|
||||
|
Health Care - 15.9%
|
|||||
|
Health Care Equipment & Supplies - 1.9%
|
|||||
|
Becton Dickinson & Co.
|
256,946
|
45,918,820
|
|||
|
Health Care Providers & Services - 6.6%
|
|||||
|
CVS Health Corp.
|
671,800
|
52,501,170
|
|||
|
McKesson Corp.
|
65,358
|
53,027,560
|
|||
|
UnitedHealth Group Inc.
|
150,913
|
51,545,844
|
|||
|
Total Health Care Providers & Services
|
157,074,574
|
||||
|
Life Sciences Tools & Services - 2.7%
|
|||||
|
Thermo Fisher Scientific Inc.
|
111,252
|
63,123,272
|
|||
|
Pharmaceuticals - 4.7%
|
|||||
|
AstraZeneca PLC, ADR
|
313,400
|
25,824,160
|
|||
|
Haleon PLC, ADR
|
3,577,721
|
33,165,473
|
|||
|
Johnson & Johnson
|
275,101
|
51,958,326
|
|||
|
Total Pharmaceuticals
|
110,947,959
|
||||
|
|
|||||
|
Total Health Care
|
377,064,625
|
||||
|
Industrials - 13.8%
|
|||||
|
Aerospace & Defense - 4.5%
|
|||||
|
Boeing Co.
|
148,600
|
29,871,572
*
|
|||
|
Northrop Grumman Corp.
|
45,863
|
26,758,767
|
|||
|
RTX Corp.
|
280,132
|
50,003,562
|
|||
|
Total Aerospace & Defense
|
106,633,901
|
||||
|
Commercial Services & Supplies - 0.9%
|
|||||
|
Veralto Corp.
|
228,046
|
22,503,579
|
|||
|
Security
|
|
|
|
Shares
|
Value
|
|
|
|||||
|
Ground Transportation - 2.2%
|
|||||
|
XPO Inc.
|
367,743
|
$52,907,186
*
|
|||
|
Machinery - 6.2%
|
|||||
|
Deere & Co.
|
109,086
|
50,357,370
|
|||
|
Illinois Tool Works Inc.
|
91,765
|
22,383,319
|
|||
|
Otis Worldwide Corp.
|
280,910
|
26,057,212
|
|||
|
Parker-Hannifin Corp.
|
62,171
|
48,047,614
|
|||
|
Total Machinery
|
146,845,515
|
||||
|
|
|||||
|
Total Industrials
|
328,890,181
|
||||
|
Information Technology - 11.3%
|
|||||
|
Communications Equipment - 1.7%
|
|||||
|
Motorola Solutions Inc.
|
99,592
|
40,505,062
|
|||
|
Semiconductors & Semiconductor Equipment - 8.5%
|
|||||
|
Broadcom Inc.
|
165,132
|
61,037,741
|
|||
|
Intel Corp.
|
1,138,669
|
45,535,374
*
|
|||
|
Microchip Technology Inc.
|
761,943
|
47,560,482
|
|||
|
Taiwan Semiconductor Manufacturing Co. Ltd., ADR
|
158,000
|
47,467,940
|
|||
|
Total Semiconductors & Semiconductor Equipment
|
201,601,537
|
||||
|
Software - 1.1%
|
|||||
|
Microsoft Corp.
|
51,558
|
26,697,248
|
|||
|
|
|||||
|
Total Information Technology
|
268,803,847
|
||||
|
Materials - 6.4%
|
|||||
|
Chemicals - 4.3%
|
|||||
|
Air Products & Chemicals Inc.
|
242,571
|
58,845,299
|
|||
|
Sherwin-Williams Co.
|
122,806
|
42,360,701
|
|||
|
Total Chemicals
|
101,206,000
|
||||
|
Construction Materials - 2.1%
|
|||||
|
Martin Marietta Materials Inc.
|
83,067
|
50,928,378
|
|||
|
|
|||||
|
Total Materials
|
152,134,378
|
||||
|
Real Estate - 1.1%
|
|||||
|
Specialized REITs - 1.1%
|
|||||
|
American Tower Corp.
|
144,988
|
25,949,952
|
|||
|
|
|||||
|
Utilities - 5.9%
|
|||||
|
Multi-Utilities - 5.9%
|
|||||
|
Sempra
|
905,715
|
83,271,437
|
|||
|
WEC Energy Group Inc.
|
519,647
|
58,060,159
|
|||
|
|
|||||
|
Total Utilities
|
141,331,596
|
||||
|
Total Investments before Short-Term Investments (Cost - $1,373,348,565)
|
2,332,742,489
|
||||
|
Security
|
|
Rate
|
|
Shares
|
Value
|
|
Short-Term Investments - 2.0%
|
|||||
|
JPMorgan 100% U.S. Treasury Securities Money Market
Fund, Institutional Class
|
3.833%
|
23,674,867
|
$23,674,867
(a)
|
||
|
Western Asset Premier Institutional U.S. Treasury
Reserves, Premium Shares
|
3.896%
|
23,674,867
|
23,674,867
(a)(b)
|
||
|
|
|||||
|
Total Short-Term Investments (Cost - $47,349,734)
|
47,349,734
|
||||
|
Total Investments - 100.0% (Cost - $1,420,698,299)
|
2,380,092,223
|
||||
|
Liabilities in Excess of Other Assets - (0.0)%††
|
(415,691
)
|
||||
|
Total Net Assets - 100.0%
|
$2,379,676,532
|
||||
|
††
|
Represents less than 0.1%.
|
|
*
|
Non-income producing security.
|
|
(a)
|
Rate shown is one-day yield as of the end of the reporting period.
|
|
(b)
|
In this instance, as defined in the Investment Company Act of 1940, an "Affiliated Company"represents Fund
ownership of at least 5% of the outstanding voting securities of an issuer, or a company which is under common
ownership or control with the Fund. At October 31, 2025, the total market value of investments in Affiliated
Companies was $23,674,867 and the cost was $23,674,867 (Note 8).
|
|
Abbreviation(s) used in this schedule:
|
||
|
ADR
|
-
|
American Depositary Receipts
|
|
Assets:
|
|
|
Investments in unaffiliated securities, at value (Cost - $1,397,023,432)
|
$2,356,417,356
|
|
Investments in affiliated securities, at value (Cost - $23,674,867)
|
23,674,867
|
|
Dividends receivable from unaffiliated investments
|
2,840,638
|
|
Receivable for Fund shares sold
|
471,128
|
|
Dividends receivable from affiliated investments
|
34,311
|
|
Prepaid expenses
|
237,159
|
|
Total Assets
|
2,383,675,459
|
|
Liabilities:
|
|
|
Payable for Fund shares repurchased
|
2,013,356
|
|
Investment management fee payable
|
1,084,180
|
|
Transfer agent fees payable
|
468,254
|
|
Service and/or distribution fees payable
|
236,804
|
|
Trustees' fees payable
|
4,139
|
|
Accrued expenses
|
192,194
|
|
Total Liabilities
|
3,998,927
|
|
Total Net Assets
|
$2,379,676,532
|
|
Net Assets:
|
|
|
Par value (Note 7)
|
$562
|
|
Paid-in capital in excess of par value
|
1,188,437,210
|
|
Total distributable earnings (loss)
|
1,191,238,760
|
|
Total Net Assets
|
$2,379,676,532
|
|
Net Assets:
|
|
|
Class 1
|
$181,279,106
|
|
Class A
|
$1,060,454,941
|
|
Class C
|
$11,138,049
|
|
Class R
|
$2,595,813
|
|
Class I
|
$880,421,541
|
|
Class IS
|
$243,787,082
|
|
Shares Outstanding:
|
|
|
Class 1
|
4,273,086
|
|
Class A
|
25,000,912
|
|
Class C
|
274,028
|
|
Class R
|
61,230
|
|
Class I
|
20,804,042
|
|
Class IS
|
5,757,910
|
|
Net Asset Value:
|
|
|
Class 1 (and redemption price)
|
$42.42
|
|
Class A (and redemption price)
|
$42.42
|
|
Class C*
|
$40.65
|
|
Class R (and redemption price)
|
$42.39
|
|
Class I (and redemption price)
|
$42.32
|
|
Class IS (and redemption price)
|
$42.34
|
|
Maximum Public Offering Price Per Share:
|
|
|
Class A (based on maximum initial sales charge of 5.50%)
|
$44.89
|
|
*
|
Redemption price per share is NAV of Class C shares reduced by a 1.00% CDSC if shares are redeemed within
one year from purchase payment (Note 2).
|
|
Investment Income:
|
|
|
Dividends from unaffiliated investments
|
$43,448,171
|
|
Dividends from affiliated investments
|
704,913
|
|
Less: Foreign taxes withheld
|
(72,670
)
|
|
Total Investment Income
|
44,080,414
|
|
Expenses:
|
|
|
Investment management fee (Note 2)
|
11,928,491
|
|
Performance adjustment (Note 2)
|
(2,439,501
)
|
|
Service and/or distribution fees (Notes 2 and 5)
|
2,770,984
|
|
Transfer agent fees (Notes 2 and 5)
|
1,771,441
|
|
Custody fees
|
278,572
|
|
Registration fees
|
125,578
|
|
Trustees' fees
|
124,389
|
|
Legal fees
|
117,697
|
|
Fund accounting fees
|
98,908
|
|
Shareholder reports
|
58,406
|
|
Audit and tax fees
|
36,344
|
|
Commitment fees (Note 9)
|
21,073
|
|
Insurance
|
18,397
|
|
Interest expense
|
12,806
|
|
Miscellaneous expenses
|
26,913
|
|
Total Expenses
|
14,950,498
|
|
Less: Fee waivers and/or expense reimbursements (Notes 2 and 5)
|
(52,817
)
|
|
Net Expenses
|
14,897,681
|
|
Net Investment Income
|
29,182,733
|
|
Realized and Unrealized Gain (Loss) on Investments (Notes 1, 3 and 10):
|
|
|
Net Realized Gain From Unaffiliated Investment Transactions
|
427,415,611
|
|
Change in Net Unrealized Appreciation (Depreciation) From Unaffiliated
Investments
|
(265,651,099
)
|
|
Net Gain on Investments
|
161,764,512
|
|
Increase in Net Assets From Operations
|
$190,947,245
|
|
For the Years Ended October 31,
|
2025
|
2024
|
|
Operations:
|
||
|
Net investment income
|
$29,182,733
|
$41,285,890
|
|
Net realized gain
|
427,415,611
|
247,504,748
|
|
Change in net unrealized appreciation (depreciation)
|
(265,651,099
)
|
280,372,277
|
|
Increase in Net Assets From Operations
|
190,947,245
|
569,162,915
|
|
Distributions to Shareholders From (Notes 1 and 6):
|
||
|
Total distributable earnings
|
(252,977,629
)
|
(92,929,183
)
|
|
Decrease in Net Assets From Distributions to Shareholders
|
(252,977,629
)
|
(92,929,183
)
|
|
Fund Share Transactions (Note 7):
|
||
|
Net proceeds from sale of shares
|
208,681,128
|
425,480,501
|
|
Reinvestment of distributions
|
235,142,359
|
86,542,844
|
|
Cost of shares repurchased
|
(792,494,792
)
|
(586,625,322
)
|
|
Shares redeemed in-kind (Note 10)
|
(263,323,522
)
|
-
|
|
Decrease in Net Assets From Fund Share Transactions
|
(611,994,827
)
|
(74,601,977
)
|
|
Increase (Decrease) in Net Assets
|
(674,025,211
)
|
401,631,755
|
|
Net Assets:
|
||
|
Beginning of year
|
3,053,701,743
|
2,652,069,988
|
|
End of year
|
$2,379,676,532
|
$3,053,701,743
|
|
For a share of each class of beneficial interest outstanding throughout each year ended October 31:
|
|||||
|
Class 1 Shares1
|
2025
|
2024
|
2023
|
2022
|
2021
|
|
Net asset value, beginning of year
|
$43.92
|
$37.26
|
$36.07
|
$40.60
|
$30.56
|
|
Income (loss) from operations:
|
|||||
|
Net investment income
|
0.54
|
0.61
|
0.54
|
0.47
|
0.43
|
|
Net realized and unrealized gain (loss)
|
2.52
|
7.38
|
1.26
|
(2.92
)
|
12.15
|
|
Total income (loss) from operations
|
3.06
|
7.99
|
1.80
|
(2.45)
|
12.58
|
|
Less distributions from:
|
|||||
|
Net investment income
|
(0.55
)
|
(0.58
)
|
(0.55
)
|
(0.49
)
|
(0.38
)
|
|
Net realized gains
|
(4.01
)
|
(0.75
)
|
(0.06
)
|
(1.59
)
|
(2.16
)
|
|
Total distributions
|
(4.56
)
|
(1.33
)
|
(0.61
)
|
(2.08
)
|
(2.54
)
|
|
Net asset value, end of year
|
$42.42
|
$43.92
|
$37.26
|
$36.07
|
$40.60
|
|
Total return2
|
7.84
%
|
21.72
%
|
4.97
%
|
(6.18
)%
|
43.15
%
|
|
Net assets, end of year (millions)
|
$181
|
$185
|
$166
|
$172
|
$199
|
|
Ratios to average net assets:
|
|||||
|
Gross expenses
|
0.52
%
|
0.51
%
|
0.61
%
|
0.62
%
|
0.61
%
|
|
Net expenses3,4
|
0.52
|
0.51
|
0.61
|
0.62
|
0.61
|
|
Net investment income
|
1.33
|
1.47
|
1.45
|
1.25
|
1.15
|
|
Portfolio turnover rate
|
18
%5
|
22
%
|
18
%
|
17
%
|
22
%
|
|
1
|
Per share amounts have been calculated using the average shares method.
|
|
2
|
Performance figures may reflect compensating balance arrangements, fee waivers and/or expense reimbursements.
In the absence of compensating balance arrangements, fee waivers and/or expense reimbursements, the total
return would have been lower. Past performance is no guarantee of future results.
|
|
3
|
As a result of an expense limitation arrangement, effective June 24, 2021, the ratio of total annual fund operating
expenses, other than interest, brokerage commissions, taxes, extraordinary expenses and acquired fund fees and
expenses, to average net assets of Class 1 shares did not exceed 0.95%. This expense limitation arrangement
cannot be terminated prior to December 31, 2027 without the Board of Trustees' consent. In addition, the manager
has agreed to waive the Fund's management fee to an extent sufficient to offset the net management fee payable
in connection with any investment in an affiliated money market fund.
|
|
4
|
Reflects fee waivers and/or expense reimbursements.
|
|
5
|
Excludes securities delivered as a result of a redemption in-kind.
|
|
For a share of each class of beneficial interest outstanding throughout each year ended October 31:
|
|||||
|
Class A Shares1
|
2025
|
2024
|
2023
|
2022
|
2021
|
|
Net asset value, beginning of year
|
$43.92
|
$37.27
|
$36.08
|
$40.61
|
$30.57
|
|
Income (loss) from operations:
|
|||||
|
Net investment income
|
0.43
|
0.50
|
0.47
|
0.40
|
0.35
|
|
Net realized and unrealized gain (loss)
|
2.52
|
7.38
|
1.26
|
(2.92
)
|
12.17
|
|
Total income (loss) from operations
|
2.95
|
7.88
|
1.73
|
(2.52)
|
12.52
|
|
Less distributions from:
|
|||||
|
Net investment income
|
(0.44
)
|
(0.48
)
|
(0.48
)
|
(0.42
)
|
(0.32
)
|
|
Net realized gains
|
(4.01
)
|
(0.75
)
|
(0.06
)
|
(1.59
)
|
(2.16
)
|
|
Total distributions
|
(4.45
)
|
(1.23
)
|
(0.54
)
|
(2.01
)
|
(2.48
)
|
|
Net asset value, end of year
|
$42.42
|
$43.92
|
$37.27
|
$36.08
|
$40.61
|
|
Total return2
|
7.53
%
|
21.38
%
|
4.81
%
|
(6.35
)%
|
42.83
%
|
|
Net assets, end of year (millions)
|
$1,060
|
$1,095
|
$914
|
$850
|
$851
|
|
Ratios to average net assets:
|
|||||
|
Gross expenses
|
0.79
%
|
0.77
%
|
0.87
%
|
0.89
%
|
0.86
%
|
|
Net expenses3,4
|
0.79
|
0.77
|
0.79
|
0.79
|
0.81
|
|
Net investment income
|
1.06
|
1.20
|
1.27
|
1.09
|
0.94
|
|
Portfolio turnover rate
|
18
%5
|
22
%
|
18
%
|
17
%
|
22
%
|
|
1
|
Per share amounts have been calculated using the average shares method.
|
|
2
|
Performance figures, exclusive of sales charges, may reflect compensating balance arrangements, fee waivers
and/or expense reimbursements. In the absence of compensating balance arrangements, fee waivers and/or
expense reimbursements, the total return would have been lower. Past performance is no guarantee of future
results.
|
|
3
|
As a result of an expense limitation arrangement, effective May 21, 2021, the ratio of total annual fund operating
expenses, other than interest, brokerage commissions, taxes, extraordinary expenses and acquired fund fees and
expenses, to average net assets of Class A shares did not exceed 0.79%. This expense limitation arrangement
cannot be terminated prior to December 31, 2027 without the Board of Trustees' consent. In addition, the manager
has agreed to waive the Fund's management fee to an extent sufficient to offset the net management fee payable
in connection with any investment in an affiliated money market fund. Prior to May 21, 2021, the expense
limitation was 1.15%.
|
|
4
|
Reflects fee waivers and/or expense reimbursements.
|
|
5
|
Excludes securities delivered as a result of a redemption in-kind.
|
|
For a share of each class of beneficial interest outstanding throughout each year ended October 31:
|
|||||
|
Class C Shares1
|
2025
|
2024
|
2023
|
2022
|
2021
|
|
Net asset value, beginning of year
|
$42.25
|
$35.92
|
$34.79
|
$39.22
|
$29.61
|
|
Income (loss) from operations:
|
|||||
|
Net investment income
|
0.12
|
0.19
|
0.16
|
0.09
|
0.06
|
|
Net realized and unrealized gain (loss)
|
2.42
|
7.09
|
1.22
|
(2.81
)
|
11.76
|
|
Total income (loss) from operations
|
2.54
|
7.28
|
1.38
|
(2.72)
|
11.82
|
|
Less distributions from:
|
|||||
|
Net investment income
|
(0.13
)
|
(0.20
)
|
(0.19
)
|
(0.12
)
|
(0.05
)
|
|
Net realized gains
|
(4.01
)
|
(0.75
)
|
(0.06
)
|
(1.59
)
|
(2.16
)
|
|
Total distributions
|
(4.14
)
|
(0.95
)
|
(0.25
)
|
(1.71
)
|
(2.21
)
|
|
Net asset value, end of year
|
$40.65
|
$42.25
|
$35.92
|
$34.79
|
$39.22
|
|
Total return2
|
6.72
%
|
20.49
%
|
3.94
%
|
(7.10
)%
|
41.70
%
|
|
Net assets, end of year (000s)
|
$11,138
|
$14,852
|
$14,941
|
$14,789
|
$17,806
|
|
Ratios to average net assets:
|
|||||
|
Gross expenses
|
1.54
%
|
1.52
%
|
1.60
%
|
1.62
%
|
1.59
%
|
|
Net expenses3,4
|
1.54
|
1.52
|
1.60
|
1.62
|
1.59
|
|
Net investment income
|
0.31
|
0.46
|
0.46
|
0.25
|
0.18
|
|
Portfolio turnover rate
|
18
%5
|
22
%
|
18
%
|
17
%
|
22
%
|
|
1
|
Per share amounts have been calculated using the average shares method.
|
|
2
|
Performance figures, exclusive of CDSC, may reflect compensating balance arrangements, fee waivers and/or
expense reimbursements. In the absence of compensating balance arrangements, fee waivers and/or expense
reimbursements, the total return would have been lower. Past performance is no guarantee of future results.
|
|
3
|
As a result of an expense limitation arrangement, the ratio of total annual fund operating expenses, other than
interest, brokerage commissions, taxes, extraordinary expenses and acquired fund fees and expenses, to average
net assets of Class C shares did not exceed 1.90%. This expense limitation arrangement cannot be terminated
prior to December 31, 2027 without the Board of Trustees' consent. In addition, the manager has agreed to waive
the Fund's management fee to an extent sufficient to offset the net management fee payable in connection with
any investment in an affiliated money market fund.
|
|
4
|
Reflects fee waivers and/or expense reimbursements.
|
|
5
|
Excludes securities delivered as a result of a redemption in-kind.
|
|
For a share of each class of beneficial interest outstanding throughout each year ended October 31:
|
|||||
|
Class R Shares1
|
2025
|
2024
|
2023
|
2022
|
2021
|
|
Net asset value, beginning of year
|
$43.92
|
$37.29
|
$36.11
|
$40.66
|
$30.63
|
|
Income (loss) from operations:
|
|||||
|
Net investment income
|
0.25
|
0.30
|
0.24
|
0.20
|
0.16
|
|
Net realized and unrealized gain (loss)
|
2.52
|
7.39
|
1.27
|
(2.92
)
|
12.19
|
|
Total income (loss) from operations
|
2.77
|
7.69
|
1.51
|
(2.72)
|
12.35
|
|
Less distributions from:
|
|||||
|
Net investment income
|
(0.29
)
|
(0.31
)
|
(0.27
)
|
(0.24
)
|
(0.16
)
|
|
Net realized gains
|
(4.01
)
|
(0.75
)
|
(0.06
)
|
(1.59
)
|
(2.16
)
|
|
Total distributions
|
(4.30
)
|
(1.06
)
|
(0.33
)
|
(1.83
)
|
(2.32
)
|
|
Net asset value, end of year
|
$42.39
|
$43.92
|
$37.29
|
$36.11
|
$40.66
|
|
Total return2
|
7.08
%
|
20.83
%
|
4.18
%
|
(6.86
)%
|
42.13
%
|
|
Net assets, end of year (000s)
|
$2,596
|
$1,231
|
$736
|
$459
|
$392
|
|
Ratios to average net assets:
|
|||||
|
Gross expenses
|
1.21
%
|
1.23
%
|
1.40
%
|
1.35
%
|
1.32
%
|
|
Net expenses3
|
1.21
4
|
1.23
4
|
1.40
4
|
1.35
4
|
1.32
|
|
Net investment income
|
0.62
|
0.72
|
0.64
|
0.55
|
0.42
|
|
Portfolio turnover rate
|
18
%5
|
22
%
|
18
%
|
17
%
|
22
%
|
|
1
|
Per share amounts have been calculated using the average shares method.
|
|
2
|
Performance figures may reflect compensating balance arrangements, fee waivers and/or expense reimbursements.
In the absence of compensating balance arrangements, fee waivers and/or expense reimbursements, the total
return would have been lower. Past performance is no guarantee of future results.
|
|
3
|
As a result of an expense limitation arrangement, the ratio of total annual fund operating expenses, other than
interest, brokerage commissions, taxes, extraordinary expenses and acquired fund fees and expenses, to average
net assets of Class R shares did not exceed 1.40%. This expense limitation arrangement cannot be terminated
prior to December 31, 2027 without the Board of Trustees' consent. In addition, the manager has agreed to waive
the Fund's management fee to an extent sufficient to offset the net management fee payable in connection with
any investment in an affiliated money market fund.
|
|
4
|
Reflects fee waivers and/or expense reimbursements.
|
|
5
|
Excludes securities delivered as a result of a redemption in-kind.
|
|
For a share of each class of beneficial interest outstanding throughout each year ended October 31:
|
|||||
|
Class I Shares1
|
2025
|
2024
|
2023
|
2022
|
2021
|
|
Net asset value, beginning of year
|
$43.82
|
$37.18
|
$35.98
|
$40.52
|
$30.50
|
|
Income (loss) from operations:
|
|||||
|
Net investment income
|
0.56
|
0.61
|
0.55
|
0.47
|
0.44
|
|
Net realized and unrealized gain (loss)
|
2.50
|
7.36
|
1.26
|
(2.92
)
|
12.14
|
|
Total income (loss) from operations
|
3.06
|
7.97
|
1.81
|
(2.45)
|
12.58
|
|
Less distributions from:
|
|||||
|
Net investment income
|
(0.55
)
|
(0.58
)
|
(0.55
)
|
(0.50
)
|
(0.40
)
|
|
Net realized gains
|
(4.01
)
|
(0.75
)
|
(0.06
)
|
(1.59
)
|
(2.16
)
|
|
Total distributions
|
(4.56
)
|
(1.33
)
|
(0.61
)
|
(2.09
)
|
(2.56
)
|
|
Net asset value, end of year
|
$42.32
|
$43.82
|
$37.18
|
$35.98
|
$40.52
|
|
Total return2
|
7.87
%
|
21.70
%
|
4.98
%
|
(6.17
)%
|
43.20
%
|
|
Net assets, end of year (millions)
|
$880
|
$1,054
|
$991
|
$1,233
|
$1,466
|
|
Ratios to average net assets:
|
|||||
|
Gross expenses
|
0.49
%
|
0.51
%
|
0.59
%
|
0.61
%
|
0.56
%
|
|
Net expenses3,4
|
0.48
|
0.51
|
0.59
|
0.61
|
0.56
|
|
Net investment income
|
1.36
|
1.46
|
1.48
|
1.26
|
1.18
|
|
Portfolio turnover rate
|
18
%5
|
22
%
|
18
%
|
17
%
|
22
%
|
|
1
|
Per share amounts have been calculated using the average shares method.
|
|
2
|
Performance figures may reflect compensating balance arrangements, fee waivers and/or expense reimbursements.
In the absence of compensating balance arrangements, fee waivers and/or expense reimbursements, the total
return would have been lower. Past performance is no guarantee of future results.
|
|
3
|
As a result of an expense limitation arrangement, the ratio of total annual fund operating expenses, other than
interest, brokerage commissions, taxes, extraordinary expenses and acquired fund fees and expenses, to average
net assets of Class I shares did not exceed 0.80%. This expense limitation arrangement cannot be terminated prior
to December 31, 2027 without the Board of Trustees' consent. In addition, the manager has agreed to waive the
Fund's management fee to an extent sufficient to offset the net management fee payable in connection with any
investment in an affiliated money market fund.
|
|
4
|
Reflects fee waivers and/or expense reimbursements.
|
|
5
|
Excludes securities delivered as a result of a redemption in-kind.
|
|
For a share of each class of beneficial interest outstanding throughout each year ended October 31:
|
|||||
|
Class IS Shares1
|
2025
|
2024
|
2023
|
2022
|
2021
|
|
Net asset value, beginning of year
|
$43.84
|
$37.19
|
$36.00
|
$40.54
|
$30.52
|
|
Income (loss) from operations:
|
|||||
|
Net investment income
|
0.57
|
0.64
|
0.56
|
0.50
|
0.44
|
|
Net realized and unrealized gain (loss)
|
2.52
|
7.36
|
1.26
|
(2.92
)
|
12.16
|
|
Total income (loss) from operations
|
3.09
|
8.00
|
1.82
|
(2.42)
|
12.60
|
|
Less distributions from:
|
|||||
|
Net investment income
|
(0.58
)
|
(0.60
)
|
(0.57
)
|
(0.53
)
|
(0.42
)
|
|
Net realized gains
|
(4.01
)
|
(0.75
)
|
(0.06
)
|
(1.59
)
|
(2.16
)
|
|
Total distributions
|
(4.59
)
|
(1.35
)
|
(0.63
)
|
(2.12
)
|
(2.58
)
|
|
Net asset value, end of year
|
$42.34
|
$43.84
|
$37.19
|
$36.00
|
$40.54
|
|
Total return2
|
7.92
%
|
21.81
%
|
5.04
%
|
(6.12
)%
|
43.29
%
|
|
Net assets, end of year (millions)
|
$244
|
$704
|
$566
|
$546
|
$458
|
|
Ratios to average net assets:
|
|||||
|
Gross expenses
|
0.44
%
|
0.45
%
|
0.55
%
|
0.53
%
|
0.52
%
|
|
Net expenses3,4
|
0.44
|
0.44
|
0.55
|
0.53
|
0.52
|
|
Net investment income
|
1.39
|
1.52
|
1.50
|
1.36
|
1.15
|
|
Portfolio turnover rate
|
18
%5
|
22
%
|
18
%
|
17
%
|
22
%
|
|
1
|
Per share amounts have been calculated using the average shares method.
|
|
2
|
Performance figures may reflect compensating balance arrangements, fee waivers and/or expense reimbursements.
In the absence of compensating balance arrangements, fee waivers and/or expense reimbursements, the total
return would have been lower. Past performance is no guarantee of future results.
|
|
3
|
As a result of an expense limitation arrangement, the ratio of total annual fund operating expenses, other than
interest, brokerage commissions, taxes, extraordinary expenses and acquired fund fees and expenses, to average
net assets of Class IS shares did not exceed 0.70%. In addition, the ratio of total annual fund operating expenses
for Class IS shares did not exceed the ratio of total annual fund operating expenses for Class I shares. These
expense limitation arrangements cannot be terminated prior to December 31, 2027 without the Board of Trustees'
consent. In addition, the manager has agreed to waive the Fund's management fee to an extent sufficient to offset
the net management fee payable in connection with any investment in an affiliated money market fund.
|
|
4
|
Reflects fee waivers and/or expense reimbursements.
|
|
5
|
Excludes securities delivered as a result of a redemption in-kind.
|
|
ASSETS
|
||||
|
Description
|
Quoted Prices
(Level 1)
|
Other Significant
Observable Inputs
(Level 2)
|
Significant
Unobservable
Inputs
(Level 3)
|
Total
|
|
Common Stocks†
|
$2,332,742,489
|
-
|
-
|
$2,332,742,489
|
|
Short-Term Investments†
|
47,349,734
|
-
|
-
|
47,349,734
|
|
Total Investments
|
$2,380,092,223
|
-
|
-
|
$2,380,092,223
|
|
†
|
See Schedule of Investments for additional detailed categorizations.
|
|
|
Total Distributable
Earnings (Loss)
|
Paid-in
Capital
|
|
(a)
|
$(195,756,223)
|
$195,756,223
|
|
Average Daily Net Assets
|
Annual Rate
|
|
First $350 million
|
0.650
%
|
|
Next $150 million
|
0.550
|
|
Next $250 million
|
0.525
|
|
Next $250 million
|
0.500
|
|
Over $1 billion
|
0.450
|
|
|
Class A
|
Class C
|
|
Sales charges
|
$95,970
|
-
|
|
CDSCs
|
26,524
|
$1,521
|
|
Purchases
|
$436,260,581
|
|
Sales
|
997,221,480
*
|
|
*
|
Excludes value of securities delivered as a result of redemptions in-kind totaling $256,435,670 (Note 10).
|
|
|
Cost
|
Gross
Unrealized
Appreciation
|
Gross
Unrealized
Depreciation
|
Net
Unrealized
Appreciation
|
|
Securities
|
$1,413,241,002
|
$1,011,260,782
|
$(44,409,561)
|
$966,851,221
|
|
|
Service and/or
Distribution Fees
|
Transfer Agent
Fees
|
|
Class 1
|
-
|
$155,753
|
|
Class A
|
$2,635,571
|
1,147,625
|
|
Class C
|
126,688
|
13,074
|
|
Class R
|
8,725
|
4,855
|
|
Class I
|
-
|
441,442
|
|
Class IS
|
-
|
8,692
|
|
Total
|
$2,770,984
|
$1,771,441
|
|
|
Waivers/Expense
Reimbursements
|
|
Class 1
|
$1,430
|
|
Class A
|
42,133
|
|
Class C
|
101
|
|
Class R
|
14
|
|
Class I
|
7,002
|
|
Class IS
|
2,137
|
|
Total
|
$52,817
|
|
|
Year Ended
October 31, 2025
|
Year Ended
October 31, 2024
|
|
Net Investment Income:
|
||
|
Class 1
|
$2,356,209
|
$2,517,590
|
|
Class A
|
11,094,282
|
12,075,079
|
|
Class C
|
41,052
|
76,284
|
|
Class R
|
12,910
|
8,388
|
|
Class I
|
11,767,739
|
14,535,361
|
|
Class IS
|
3,408,344
|
9,695,182
|
|
Total
|
$28,680,536
|
$38,907,884
|
|
Net Realized Gains:
|
||
|
Class 1
|
$16,649,387
|
$3,328,418
|
|
Class A
|
99,626,881
|
18,664,592
|
|
Class C
|
1,343,251
|
304,348
|
|
Class R
|
138,998
|
15,313
|
|
Class I
|
83,755,594
|
19,982,469
|
|
Class IS
|
22,782,982
|
11,726,159
|
|
Total
|
$224,297,093
|
$54,021,299
|
|
|
Year Ended
October 31, 2025
|
Year Ended
October 31, 2024
|
||
|
|
Shares
|
Amount
|
Shares
|
Amount
|
|
Class 1
|
||||
|
Shares sold
|
-
|
-
|
-
|
-
|
|
Shares issued on reinvestment
|
479,705
|
$19,005,525
|
141,670
|
$5,846,008
|
|
Shares repurchased
|
(411,276
)
|
(16,827,108
)
|
(403,488
)
|
(16,994,268
)
|
|
Net increase (decrease)
|
68,429
|
$2,178,417
|
(261,818
)
|
$(11,148,260
)
|
|
Class A
|
||||
|
Shares sold
|
1,996,153
|
$81,484,645
|
3,096,351
|
$128,163,371
|
|
Shares issued on reinvestment
|
2,698,275
|
106,866,693
|
717,568
|
29,566,382
|
|
Shares repurchased
|
(4,631,078
)
|
(188,141,445
)
|
(3,393,419
)
|
(142,123,113
)
|
|
Net increase
|
63,350
|
$209,893
|
420,500
|
$15,606,640
|
|
Class C
|
||||
|
Shares sold
|
27,226
|
$1,064,746
|
72,022
|
$2,876,858
|
|
Shares issued on reinvestment
|
34,095
|
1,293,635
|
8,938
|
351,831
|
|
Shares repurchased
|
(138,786
)
|
(5,407,481
)
|
(145,415
)
|
(5,813,535
)
|
|
Net decrease
|
(77,465
)
|
$(3,049,100
)
|
(64,455
)
|
$(2,584,846
)
|
|
Class R
|
||||
|
Shares sold
|
43,556
|
$1,824,052
|
14,269
|
$601,610
|
|
Shares issued on reinvestment
|
3,831
|
151,908
|
575
|
23,701
|
|
Shares repurchased
|
(14,187
)
|
(586,268
)
|
(6,540
)
|
(280,807
)
|
|
Net increase
|
33,200
|
$1,389,692
|
8,304
|
$344,504
|
|
Class I
|
||||
|
Shares sold
|
1,624,400
|
$66,922,062
|
3,318,421
|
$137,749,918
|
|
Shares issued on reinvestment
|
2,142,484
|
84,677,419
|
734,176
|
30,214,010
|
|
Shares repurchased
|
(7,019,688
)
|
(294,959,681
)
|
(6,645,535
)
|
(277,747,460
)
|
|
Net decrease
|
(3,252,804
)
|
$(143,360,200
)
|
(2,592,938
)
|
$(109,783,532
)
|
|
Class IS
|
||||
|
Shares sold
|
1,396,233
|
$57,385,623
|
3,743,357
|
$156,088,744
|
|
Shares issued on reinvestment
|
585,290
|
23,147,179
|
498,051
|
20,540,912
|
|
Shares repurchased
|
(6,620,448
)
|
(286,572,809
)
|
(3,399,514
)
|
(143,666,139
)
|
|
Shares redeemed in-kind
|
(5,654,360
)
|
(263,323,522
)
|
-
|
-
|
|
Net increase (decrease)
|
(10,293,285
)
|
$(469,363,529
)
|
841,894
|
$32,963,517
|
|
|
Affiliate
Value at
October 31,
2024
|
Purchased
|
Sold
|
||
|
Cost
|
Shares
|
Proceeds
|
Shares
|
||
|
Western Asset
Premier
Institutional U.S.
Treasury Reserves,
Premium Shares
|
$16,364,204
|
$174,079,091
|
174,079,091
|
$166,768,428
|
166,768,428
|
|
(cont'd)
|
Realized
Gain (Loss)
|
Dividend
Income
|
Net Increase
(Decrease) in
Unrealized
Appreciation
(Depreciation)
|
Affiliate
Value at
October 31,
2025
|
|
Western Asset Premier
Institutional U.S.
Treasury Reserves,
Premium Shares
|
-
|
$704,913
|
-
|
$23,674,867
|
|
|
2025
|
2024
|
|
Distributions paid from:
|
||
|
Ordinary income
|
$31,000,374
|
$64,972,760
|
|
Net long-term capital gains
|
221,977,255
|
27,956,423
|
|
Total distributions paid
|
$252,977,629
|
$92,929,183
|
|
Undistributed ordinary income - net
|
$2,653,730
|
|
Undistributed long-term capital gains - net
|
221,733,809
|
|
Total undistributed earnings
|
$224,387,539
|
|
Unrealized appreciation (depreciation)(a)
|
966,851,221
|
|
Total distributable earnings (loss) - net
|
$1,191,238,760
|
|
(a)
|
The difference between book-basis and tax-basis unrealized appreciation (depreciation) is attributable to the tax
deferral of losses on wash sales and Partnership basis adjustments.
|
|
|
Pursuant to:
|
Amount Reported
|
|
Long-Term Capital Gain Dividends Distributed
|
§852(b)(3)(C)
|
$277,920,025
|
|
Income Eligible for Dividends Received Deduction (DRD)
|
§854(b)(1)(A)
|
$40,496,113
|
|
Qualified Dividend Income Earned (QDI)
|
§854(b)(1)(B)
|
$41,762,699
|
|
Qualified Net Interest Income (QII)
|
§871(k)(1)(C)
|
$925,592
|
|
Short-Term Capital Gain Dividends Distributed
|
§871(k)(2)(C)
|
$2,319,388
|
|
Qualified Business Income Dividends Earned
|
§199A
|
$994,837
|
|
Section 163(j) Interest Earned
|
§163(j)
|
$1,400,409
|
|
Interest Earned from Federal Obligations
|
Note (1)
|
$1,400,409
|
|
Changes in and Disagreements with Accountants
|
For the period covered by this report
|
|
Not applicable.
|
|
|
Results of Meeting(s) of Shareholders
|
For the period covered by this report
|
|
Not applicable.
|
|
|
Remuneration Paid to Directors, Officers and Others
|
For the period covered by this report
|
|
Refer to the financial statements included herein.
|
|
| ITEM 8. | CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS FOR OPEN-END MANAGEMENT INVESTMENT COMPANIES. |
The information is disclosed as part of the Financial Statements included in Item 7 of this Form N-CSR.
| ITEM 9. | PROXY DISCLOSURES FOR OPEN-END MANAGEMENT INVESTMENT COMPANIES. |
The information is disclosed as part of the Financial Statements included in Item 7 of this Form N-CSR.
| ITEM 10. | REMUNERATION PAID TO DIRECTORS, OFFICERS, AND OTHERS OF OPEN-END MANAGEMENT INVESTMENT COMPANIES. |
The information is disclosed as part of the Financial Statements included in Item 7 of this Form N-CSR.
| ITEM 11. | STATEMENT REGARDING BASIS FOR APPROVAL OF INVESTMENT ADVISORY CONTRACT. |
The information is disclosed as part of the Financial Statements included in Item 7 of this Form N-CSR, as applicable.
| ITEM 12. | DISCLOSURE OF PROXY VOTING POLICIES AND PROCEDURES FOR CLOSED-END MANAGEMENT INVESTMENT COMPANIES. |
Not applicable.
| ITEM 13. | PORTFOLIO MANAGERS OF CLOSED-END MANAGEMENT INVESTMENT COMPANIES. |
Not applicable.
| ITEM 14. | PURCHASES OF EQUITY SECURITIES BY CLOSED-END MANAGEMENT INVESTMENT COMPANY AND AFFILIATED PURCHASERS. |
Not applicable.
| ITEM 15. | SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS. |
There have been no changes to the procedures by which shareholders may recommend nominees to the Registrant's Board of Trustees that would require disclosure herein.
| ITEM 16. | CONTROLS AND PROCEDURES. |
| (a) | The Registrant's principal executive officer and principal financial officer have concluded that the Registrant's disclosure controls and procedures (as defined in Rule 30a- 3(c) under the Investment Company Act of 1940, as amended (the "1940 Act")) are effective as of a date within 90 days of the filing date of this report that includes the disclosure required by this paragraph, based on their evaluation of the disclosure controls and procedures required by Rule 30a-3(b) under the 1940 Act and 15d-15(b) under the Securities Exchange Act of 1934. |
| (b) | There were no changes in the Registrant's internal control over financial reporting (as defined in Rule 30a-3(d) under the 1940 Act) that occurred during the period covered by this report that have materially affected or are likely to materially affect the Registrant's internal control over financial reporting. |
| ITEM 17. | DISCLOSURE OF SECURITIES LENDING ACTIVITIES FOR CLOSED-END MANAGEMENT INVESTMENT COMPANIES. |
Not applicable.
| ITEM 18. | RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION. |
| (a) | Not applicable. |
| (b) | Not applicable. |
| ITEM 19. | EXHIBITS. |
Exhibit 99.CODE ETH
Exhibit 99.CERT
Exhibit 99.906CERT
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this Report to be signed on its behalf by the undersigned, there unto duly authorized.
Legg Mason Partners Investment Trust
| By: | /s/ Jane Trust | |
| Jane Trust | ||
| Chief Executive Officer |
| Date: | December 23, 2025 |
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| By: | /s/ Jane Trust | |
| Jane Trust | ||
| Chief Executive Officer |
| Date: | December 23, 2025 |
| By: | /s/ Christopher Berarducci | |
| Christopher Berarducci | ||
| Principal Financial Officer |
| Date: | December 23, 2025 |